Related Experiment Videos

Aicardi-Goutières syndrome: an update and results of interferon-alpha studies

F Goutières1, J Aicardi, P G Barth

  • 1Neuropediatric Unit, Hôpital des Enfants Malades, Paris, France.

Annals of Neurology
|December 16, 1998
PubMed

Insights

Aicardi-Goutières syndrome, a familial encephalopathy, presents with basal ganglia calcification and chronic cerebrospinal fluid (CSF) lymphocytosis. High interferon-alpha levels suggest a role in this progressive neurodegenerative disorder.

Area of Science:

  • Neurology
  • Genetics
  • Immunology

Background:

  • Aicardi-Goutières syndrome is a rare genetic disorder characterized by encephalopathy, basal ganglia calcification, and chronic cerebrospinal fluid (CSF) lymphocytosis.
  • The syndrome's clinical presentation and progression can vary significantly among affected individuals.

Purpose of the Study:

  • To review clinical, imaging, and laboratory findings in patients with Aicardi-Goutières syndrome.
  • To investigate the role of interferon-alpha in the pathogenesis of the disorder.
  • To support the autosomal recessive inheritance pattern of Aicardi-Goutières syndrome.

Main Methods:

  • Retrospective review of 27 patients with Aicardi-Goutières syndrome.
  • Analysis of neuroimaging (brain atrophy, calcification), CSF analysis (lymphocytosis), and serum/CSF interferon-alpha levels.
  • Neuropathological examination in two patients.

Main Results:

  • Early onset (within 4 months) and microcephaly were common in pediatric patients.
  • All patients exhibited severe, progressive brain atrophy; calcification patterns varied.
  • Persistent CSF lymphocytosis and elevated serum/CSF interferon-alpha levels were observed in a significant proportion of patients, suggesting intrathecal synthesis.
  • Profound disability was noted in surviving patients, though severity varied.

Conclusions:

  • Aicardi-Goutières syndrome is a severe neurodegenerative disorder with autosomal recessive inheritance.
  • Elevated interferon-alpha levels are a key feature and may contribute to the disease's pathogenesis.
  • Despite variable presentation, the syndrome leads to significant neurological impairment.

Related Concept Videos